Skip to main content
Caplight Logo









NorFalk

NorFalk

Private
DenmarkEnergy & Sustainabilityhttps://nor-falk.com/

Last Round

Convertible Debt

Mar 7, 2024

Total Funding Raised

$1.98M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

NorFalk is a biotechnology company that develops and produces sustainable, bio-based surfactants as alternatives to fossil-derived or palm oil-based ingredients for the cosmetics and personal care industry.

Sector

Energy & Sustainability

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

bio-based surfactantsbiocatalysisgreen chemistrysustainable ingredientsclean beautyspecialty chemicalsbiodegradable surfactantsenzymatic synthesispalm oil alternativesbiotech manufacturingbio-surfactantssustainable manufacturingpersonal care ingredientshome care chemicalsbio-based feedstocks

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NorFalk Comparables

Compare NorFalk with similar companies based on industry and business-model similarity.

NorFalk comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AmphiStar
86%
Holiferm
83%
Dispersa
83%

NorFalk Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtMar 7, 2024
Pre SeedJun 1, 2023

Key People

Founding team and executive leadership

Kasper Olesen Falkenberg

CEO, Co-founder

Founding Team

NorFalk Investors

Notable investors and investment history

NorFalk investors
InvestorRounds
ChemstarsPre Seed
BioInnovation InstitutePre Seed, Convertible Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 197% MoM, reaching 3.1K.

  • Jan 30, 2026

    Monthly visitors grew 138% MoM.

NorFalk Filings

Explore SEC and related filing metadata, where available.

NorFalk filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NorFalk's valuation, stock price, and market status.

Is NorFalk a public or private company?

NorFalk is a private company.

What is the current stock price of NorFalk?

NorFalk is a private company with no public stock price. No recent secondary market data is available.

How much is NorFalk worth (valuation)?

Valuation information for NorFalk is not publicly available.

Can I buy NorFalk stock?

NorFalk shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NorFalk's last funding round?

NorFalk's most recent funding round was Convertible Debt on March 7, 2024.

Who are the main investors in NorFalk?

Key investors in NorFalk include BioInnovation Institute.

Will NorFalk IPO soon?

No public IPO plans have been announced for NorFalk.

How can I track NorFalk secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NorFalk's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDenmark
Employee Range17
Year Founded2021
Last FundingMar 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?